Pharmaceuticals and vector-control programmes have greatly diminished the once-widespread disease, but sustained effort will ...
The Danish Medicines Agency requested the EMA's Pharmacovigilance Risk Assessment Committee review reports on the ...
Azafaros B.V. today announced that its lead asset, nizubaglustat, has been granted orphan drug designation from regulatory ...
Patients with presbyopia experienced improvements in near vision after treatment with Brimochol PF in a second phase 3 ...
LONDON, Jan. 7, 2025 /PRNewswire/ -- Norgine today announced that it completed its marketing authorisation application filing ...
Diet food brands have been hit in recent years, but now GLP-1 drugs like Ozempic are hitting the market, will this spell the ...
Norgine today announced that it completed its marketing authorisation application filing to European Medicines Agency (EMA) for eflornithine in high-risk neuroblastoma (HRNB). This follows the ...
With limited treatment options available for patients with PDAC, the EMA Orphan Drug Designation and FDA Orphan Drug Designation granted to elraglusib for the same indication reflect elraglusib’s ...
Hosted on MSN2d
EMA gives OMPD to Actuate’s pancreatic cancer therapyActuate Therapeutics has gained orphan medicinal product designation (OMPD) from the European Medicines Agency (EMA) for ...
RQ Bio welcomes positive CHMP opinion on Kavigale for prevention of COVID-19 in immunocompromised individualsKavigale (sipavibart; AZD3152) is a ...
Among the health policy novelties of 2025, a new tool developed by the European Medicines Agency (EMA) is set to harmonise ...
Everest Medicines Announces the Implementation of NEFECON National Reimbursement Drug List Pricing in China for the <a target=_blank href=https:// ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback